Transaction in Own Shares
October 18, 2013 - Shire plc (LSE: SHP, NASDAQ: SHPG) (the "Company") announces
that, in accordance with the authority granted by shareholders at the Company's
Annual General Meeting on April 30, 2013, it purchased 2,700 of its ordinary
shares of 5 pence each ("Ordinary Shares") on October 17, 2013. The highest and
lowest price paid for the directly acquired Ordinary Shares was 2523.00 pence
per share and 2515.00 pence per share respectively.
The purchased shares will be held as treasury shares. Following the above
purchase, the Company holds 9,801,837 Ordinary Shares as treasury shares and
has 553,130,170 Ordinary Shares in issue (excluding treasury shares).
The purchases were made by an independent third party which makes its trading
decisions independently of, and uninfluenced by, the Company. The independence
of the third party enables the Company to continue to purchase Ordinary Shares
during close periods and other prohibited periods, should they arise. The third
party has been appointed by the Company to make purchases to December 31, 2013.
For further information please contact:
Eric Rojas email@example.com +1 781 482 0999
Sarah Elton-Farr firstname.lastname@example.org +44 1256 894157
NOTES TO EDITORS
Shire enables people with life-altering conditions to lead better lives.
Our strategy is to focus on developing and marketing innovative specialty
medicines to meet significant unmet patient needs.
We provide treatments in Neuroscience, Rare Diseases, Gastrointestinal,
Internal Medicine and Regenerative Medicine and we are developing treatments
for symptomatic conditions treated by specialist physicians in other targeted
Registered in Jersey, No. 99854, 22 Grenville Street, St Helier, Jersey JE4 8PX
-0- Oct/18/2013 07:12 GMT
Press spacebar to pause and continue. Press esc to stop.